SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Deploying AI at Hospitals Is Delicate Operation

HEALTH: Hospitals Grapple With Use, Costs and ConcernsRady Children’s Hospital holds a world record for fastest genomic diagnosis. Instrumental in the feat: artificial intelligence.

SD 500: Helen Torley

Helen Torley joined Halozyme in 2014 as president and CEO. She has led the company to annual revenue of more than $350 million and a market cap of $2.6 billion.

Tease photo

AmpliPhi Biosciences Merges With Marina Del Rey Company

M&A: Co. Will Operate as Armata Pharmaceuticals

Two companies, new name. San Diego-based AmpliPhi Biosciences and Marina del Rey’s C3J Therapeutics have merged, operating as Armata Pharmaceuticals, focused on antibiotic-resistant infections.

Ra Medical Sues Strata Skin Sciences

Carlsbad’s Ra Medical Systems on May 16 sued Strata Skin Sciences and its board chair. The lawsuit alleges a campaign of false and misleading statements to financial partners before, during and after Ra Medical’s initial public offering.

Product, Passion and Branding Hit Target

FOOD: Company Appeals to Millennial Tastes, Mindset

Food company Bonafide Provisions sells chicken, beef, turkey and frontier flavored broths and other bone broth-based food products in about 6,000 stores nationwide, including Jimbo’s…Naturally!, Sprouts Farmers Market and Whole Foods Market.

Tease photo

Office Bridges Gap Between Discovery, Therapeutics

HEALTH: Arm of Moores Cancer Center Holds Annual Symposium

A department at UC San Diego Health’s Moores Cancer Center is known for putting on a symposium to translate groundbreaking oncology discoveries into therapeutics.

Tease photo

Chinese Pharma Co. Expands Its CRO Role in San Diego

PHARMA: Acquisitions Part of CRO Consolidation Trend Locally, Nationwide

WuXi AppTec is making moves in San Diego. The Chinese pharmaceutical company earlier this month bought San Diego-based Pharmapace.

MabVax Sells Assets to German Company

BIOTECH: BioNTech Plans to Establish a Local Research Facility

The recent acquisition of San Diego’s MabVax has been a long time coming. MabVax sold its cancer drug assets and its lab equipment to German company BioNTech, it was announced earlier this month.

Halozyme Reports Revenue Of $56.9 Million for First Quarter

BIOTECH: Co. Gets Licensing Fee From Argenx

San Diego-based Halozyme reported higher revenue and net income in first quarter results, thanks to the company’s platform technology. Looking forward, the company is heading for an inflection point.

Tease photo

Former Boston Scientific Exec Joins Medical Device Incubator

Rob Abrams, a former executive with Boston Scientific and investor with Sanderling Ventures, will join medical device incubator Evolve MedTech as partner.

Boston Scientific Acquires Carlsbad’s Vertiflex for $465M Upfront

Carlsbad-based Vertiflex – maker of a device that reduces spine pressure – was acquired by Boston Scientific. The deal includes Boston Scientific paying $465 million upfront, with additional payments dependent on commercial milestones over the next three years.

Local Medtechs Report Substantial Increases in Revenue for Quarter

medicine: Costs To Scale Up Leave Some Cos. in the Red

The heavy-hitters of San Diego medtech — Dexcom, ResMed, Tandem Diabetes Care and NuVasive — saw revenue either rise or shoot up in recent quarterly results.

Tease photo

Poseida Therapeutics Gains Orphan Drug Designation

A drug candidate from Poseida Therapeutics aimed at relapsed multiple myeloma has picked up an orphan drug designation.

Illumina Sues BGI Claiming Patent Infringement

Genomics titan Illumina has filed a patent infringement lawsuit against a BGI Group subsidiary.

DTx Pharma Raises $3 Million, Hopes Its Trojan Horse Is a Winner

Health: Company Is Working on Getting Therapeutics Into Cell

DTx Pharma, a Torrey Pines startup developing a way to make more effective RNA treatments, recently raised $3 million in Series A funding. The round included investments from previous investors, including Tech Coast Angels and Friedman Bioventure.

Prev